HS2ST1 and glioblastoma: HS2ST1 expression was higher in tumor tissues compared with normal tissues in patients with diffuse large B-cell lymphomas, esophageal carcinomas, glioblastoma multiforme, pancreatic adenocarcinomas, rectal adenocarcinomas, skin cutaneous melanomas, stomach adenocarcinomas, and thymomas.